BRANFORD, Conn., April 24, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, ...

ZyVersa Therapeutics enters a $10 million share purchase agreement with Williamsburg Venture Holdings to advance kidney disease treatment development. ZyVersa Therapeutics, Inc. has announced a share ...

The latest update is out from Wave Sync ( (WAYS) ).

- Share purchase agreement further strengthens Company’s position to deliver on value-driving clinical milestones - TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (“Cybin” or ...

FB Financial ( ($FBK) ) just unveiled an update. On November 14, 2025, FB Financial Corporation entered into a share purchase agreement with the ...

WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment ...

SUNBURY, Pa., June 6, 2025 /PRNewswire/ -- Weis Markets, Inc. (WMK) (the "Company") announced effective June 6, 2025 that it has purchased in a private transaction 2,153,846 shares (the "Shares") of ...

DeFi Development Corp. (Nasdaq: DFDV), the first public U.S. company with a treasury strategy focused on accumulating Solana (SOL), has announced a share purchase agreement with RK Capital Management ...

VANCOUVER, BC, Sept. 12, 2025 /PRNewswire/ - NameSilo Technologies Corp. (CSE: URL) (PINKSHEETS: URLOF) (the "Company") is pleased to announce that it has entered into a definitive share purchase ...

MONTREAL, Feb. 6, 2025 /CNW/ - Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it has closed a share purchase agreement (the "Transaction") with ...

Tharimmune, Inc. (NASDAQ:THAR) shares are trading lower Tuesday after the company announced it has entered into a $5.3 million securities purchase agreement. What To Know: Tharimmune said it entered ...